Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Scandinavian Journal of Infectious Diseases|January 1, 1988
Norfloxacin for prevention of bacterial infections during severe granulocytopenia after bone marrow transplantationT Schmeiser, E Kurrle, R Arnold, et al.
Annals of Hematology|January 1, 1994
Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropeniaB Hertenstein, W V Kern, T Schmeiser, et al.
Virchows Archiv. B, Cell Pathology Including Molecular Pathology|January 1, 1991
Fatal B-cell lymphoproliferative syndrome in allogeneic marrow graft recipients. A clinical, immunobiological and pathological studyM Simon, C R Bartram, W Friedrich, et al.
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy|January 1, 1992
ABO-incompatible bone marrow transplantationM Wiesneth, B Hertenstein, D Bunjes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1994
Cardiac toxicity of bone marrow transplantation: predictive value of cardiologic evaluation before transplantB Hertenstein, M Stefanic, T Schmeiser, et al.
Klinische Wochenschrift|June 15, 1984
[Bone marrow transplantation in panmyelopathy, acute leukemia and chronic myelocytic leukemia: results of the Ulm Transplantation Group]R Arnold, T Schmeiser, W Friedrich, et al.
Bone Marrow Transplantation|July 1, 1989
Evaluation of remission state in chronic myeloid leukemia patients after bone marrow transplantation using cytogenetic and molecular genetic approachesR Arnold, C R Bartram, B Heinze, et al.
Transplantation|January 1, 1987
Coagulation factor XIII A and B subunits in bone marrow and liver transplantationA Wölpl, H Lattke, P G Board, et al.
Rheumatology International|July 20, 2011
Profile of gastrointestinal involvement in patients with systemic sclerosisT Schmeiser, P Saar, D Jin, et al.
Zeitschrift Fur Rheumatologie|April 19, 2020
[A cross sectional study on patients with inflammatory rheumatic diseases in terms of their compliance to their immunsuppressive medication during COVID-19 pandemic]T Schmeiser, M Broll, A Dormann, et al.
Pageof 5